RNF43 and colorectal cancer: In support of this, COLO-320DM (APC^p.S811*) and DLD-1 (RNF43^X659fs and RNF43^L214M), two colorectal cancer cell lines harboring Wnt pathway alterations, showed greater sensitivity to JPI-547 than to olaparib (Figure S5).